Amishi Drugs And Chemicals Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2005.
2005 Ahmedabad, Gujarat, India Active
Last Updated:
About Amishi Drugs And Chemicals Private Limited

Amishi Drugs And Chemicals Private Limited, a active private limited company, was established on 27 October 2005 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC046996. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.54 Cr.

Formerly known as Amishi Drugs And Chemicals Limited. It upholds a compliant status. Employing 38 professional, Its leadership includes Saurabh Saggi (Director), Suk Gu Kim (Director), Stephen Kane Latreille (Director). Past directors included Saurabh Saggi, Devarsh Dilip Patel, Jason Alexander Payant. It holds ₹16.12 Cr open charges and ₹1.34 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 622, Phase Iv Gidc, Naroda, Ahmedabad, Gujarat, 382330.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2005PTC046996

  • Registration Number

    046996

  • Incorporation Date

    27 October 2005

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹1.54 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 1.54 Cr
  • Company Age 20 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 16.12 Cr
  • Satisfied Charges ₹ 1.34 Cr
  • Revenue Growth **** 22.58%
  • Profit Growth **** 0.14%
  • Ebitda **** 2854.13%
  • Net Worth 8127.05%
  • Total Assets **** 13.93%
Company report

Amishi Drugs And Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Amishi Drugs And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Amishi Drugs And Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Saurabh Saggi Director 04 Aug 2023 Current
Suk Gu Kim Director 01 Aug 2022 Current
Stephen Kane Latreille Director 18 Apr 2024 Current
Dilipbhai Mahendrabhai Patel Person Incharge 29 Oct 2005 Current
Sriprakash Krishnan Director 01 Aug 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Sep 2023 Past
Pramod Abcsdd Director 01 Aug 2022 Past
Pramod Abcsdd Additional Director 28 Sep 2023 Past
Pramod Abcsdd Additional Director 28 Sep 2023 Past
Pramod Abcsdd Additional Director 25 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Amishi Drugs And Chemicals.

Amishi Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.58% increase. The company also saw a slight improvement in profitability, with a 0.14% increase in profit. The company's net worth Soared by an impressive increase of 8127.05%.

Amishi Drugs And Chemicals revenue growth over time
Amishi Drugs And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
22.58%
*******
*******
*******
*******
Revenue from Operations
*******
21.95%
*******
*******
*******
*******
Total Assets
*******
13.93%
*******
*******
*******
*******
Profit or Loss
*******
0.14%
*******
*******
*******
*******
Net Worth
*******
8127.05%
*******
*******
*******
*******
EBITDA
*******
2854.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Amishi Drugs And Chemicals?

In 2023, Amishi Drugs And Chemicals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹161,200,000.00

Satisfied Charges

₹13,400,000.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 16.12 Cr
Latest Charge Details
Date Lender Amount Status
09 Dec 2004 Indian Overseas Bank ₹16.12 Cr Open
04 Mar 2021 Others ₹5.40 M Satisfied
11 May 2018 Hdfc Bank Limited ₹1.00 M Satisfied
11 Dec 2017 State Bank Of India ₹3.00 M Satisfied
19 Dec 2015 Axis Bank Limited ₹4.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Amishi Drugs And Chemicals?

Amishi Drugs And Chemicals has a workforce of 38 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Amishi Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amishi Drugs And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Amishi Drugs And Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Amishi Drugs And Chemicals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Amishi Drugs And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Stephen Kane Latreille was appointed as a Director was appointed as a Director on 18 Apr 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Saurabh Saggi was appointed as a Director was appointed as a Director on 04 Aug 2023 & has been associated with this company since 2 years 7 months . was completed.

  • Charges

    The activity A charge registered on 04 Mar 2021 via Charge ID 100451904 with Others was fully satisfied on 14 Sep 2022. was completed.

  • Charges

    Progress on A charge registered on 11 Dec 2017 via Charge ID 100160346 with State Bank Of India was fully satisfied on 26 Aug 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Amishi Drugs And Chemicals Private Limited?

The CIN of Amishi Drugs And Chemicals Private Limited is U24230GJ2005PTC046996.

Where is Amishi Drugs And Chemicals Private Limited headquartered?

Amishi Drugs And Chemicals Private Limited is headquartered at Plot No. 622, Phase Iv Gidc, Naroda, Ahmedabad, Gujarat, 382330.

When was Amishi Drugs And Chemicals Private Limited incorporated?

Amishi Drugs And Chemicals Private Limited was incorporated on 27 October 2005.

Who are the current directors of Amishi Drugs And Chemicals Private Limited?

The current directors of Amishi Drugs And Chemicals Private Limited are

What is the primary industry of Amishi Drugs And Chemicals Private Limited?

The primary industry of Amishi Drugs And Chemicals Private Limited is Manufacturing.

Is Amishi Drugs And Chemicals Private Limited a listed company?

Amishi Drugs And Chemicals Private Limited is unlisted.

What is the capital structure of Amishi Drugs And Chemicals Private Limited?

The authorized capital of Amishi Drugs And Chemicals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹1.54 Cr.

What is the compliance status of Amishi Drugs And Chemicals Private Limited?

The compliance status of Amishi Drugs And Chemicals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available